Brief Reports

Subclinical onychomycosis in patients with type II diabetes

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 5 July 2015
Accepted: 7 July 2015
Published: 17 December 2015
2307
Views
868
Downloads
409
HTML

Authors

Fungal organisms could be present in the nail without any clinical manifestations. As onychomycosis in diabetics has more serious complications, early detection of such infection could be helpful to prevent them. We aim in this study to assess the possibility of detecting subclinical onychomycosis in type II diabetic patients and addressing possible associated neuropathy. A cross sectional, observational study included patients with type II diabetes with normal big toe nail. All were subjected to nail clipping of the big toe nail, followed by staining with Hematoxylin and Eosin and Periodic-Acid-Schiff (PAS) stains and examined microscopically. A total of 106 patients were included, fungal infection was identified in eight specimens, all were uncontrolled diabetes, and six had neuropathy. Using the nail clipping and microscopic examination with PAS stain to detect such subclinical infection could be an applicable screening test for diabetic patients, for early detection and management of onychomycosis.

Downloads

Download data is not yet available.

Citations

Supporting Agencies

How to Cite



1.
Elbendary A, El Tawdy A, Zaki N, Alfishawy M, Rateb A. Subclinical onychomycosis in patients with type II diabetes. Dermatol Reports [Internet]. 2015 Dec. 17 [cited 2026 Apr. 18];7(3). Available from: https://journals.pagepress.net/dr/article/view/6099